Eagle Pharmaceuticals Inc (NASDAQ: EGRX) stock closed at $9.54 on 11/9/23 after a major decline of -30.4%. The stock has been extremely weak relative to the market over the last nine months and has declined […]
Wolverine World Wide Inc. (NYSE: WWW) has reported E.P.S. of $0.11 for its third fiscal quarter (ending September 30) versus $0.49 for the same period a year ago — a decline of -78%. However, this […]
PERFORMANCE FOOD GROUP COMPANY (NYSE: PFGC) has reported E.P.S. of $0.78 for its first fiscal quarter (ending September 30) versus $0.62 for the same period a year ago — an increase of 26%. Relative to […]
Lumentum Holdings Inc (NASDAQ: LITE) has reported a loss for its first fiscal quarter (ending September 30) of $-1.02 versus a loss $-0.01 for the same period a year ago. Relative to the consensus estimate […]
On 11/8/23, Sleep Number Corp (NASDAQ: SNBR) stock suffered a major decline of -29.1%, closing at $11.37. The stock has declined -30.1% during the last week and has been weak relative to the market over […]
Mercury Systems Inc (NASDAQ: MRCY) stock suffered a major decline of -12.6% on 11/8/23. The shares closed at $32.15. The stock has declined -10.6% during the last week and has been weak relative to the […]
For its third fiscal quarter (ending September 30), ANI Pharmaceuticals Inc (NASDAQ: ANIP) has reported E.P.S. of $0.46 compared to $-0.55 a year ago. Relative to the consensus estimate of $0.84, this was a shortfall […]
Identiv Inc (NASDAQ: INVE) stock suffered a major decline of -16.3% on 11/8/23. The shares closed at $5.04. The stock has been exceptionally strong relative to the market over the last nine months but has […]
For its third fiscal quarter (ending September 30), Kellogg Co (NYSE: K) has reported a -13% decline in E.P.S. from $0.91 a year ago to $0.79 in the current quarter. This result fell short of […]
ViaSat Inc. (NASDAQ: VSAT) has reported a loss for its second fiscal quarter (ending September 30) of $-6.16 versus a loss $-0.93 for the same period a year ago. For the latest four quarters through […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research